SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-050518
Filing Date
2015-08-19
Accepted
2015-08-19 09:00:23
Documents
1
Period of Report
2015-08-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v418537_4.html 4  
1 OWNERSHIP DOCUMENT v418537_4.xml 4 3701
  Complete submission text file 0001144204-15-050518.txt   5459
Mailing Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601
Business Address 3 UNIVERSITY PLAZA DRIVE SUITE 320 HACKENSACK NJ 07601 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Issuer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SELWAY ACQUISITION CORPORATION 66 FORD ROAD, SUITE 230 DENVILLE NJ 07834
Business Address
Bibring Yoram (Reporting) CIK: 0001576822 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36641 | Film No.: 151062982